| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TROW
|
109.83 | 23.4B | 10.55 | 2.13 | 6.40 | — | — | 86 | 72 | 220.62 | +75.6% | 100 | 0.04 |
|
FIS
|
41.94 | 21.6B | 6.42 | 1.35 | 10.03 | — | — | 79 | 83 | 114.34 | +129.5% | 48 | 1.33 |
|
PYPL
|
55.66 | 47.6B | 9.71 | 2.40 | 7.23 | — | — | 77 | 76 | 108.75 | +71.5% | 75 | 0.68 |
|
NTRS
|
186.70 | 34.2B | 15.24 | 2.55 | — | — | — | 76 | 59 | 271.97 | +33.8% | 92 | 1.05 |
|
FISV
|
51.96 | 27.6B | 8.63 | 1.05 | 6.60 | — | — | 74 | 65 | 121.38 | +100.2% | 67 | 1.12 |
|
RJF
|
179.40 | 34.5B | 16.07 | 2.75 | — | — | — | 69 | 59 | 244.34 | +25.0% | 67 | 0.34 |
|
AMP
|
562.16 | 49.7B | 12.75 | 7.99 | — | — | — | 68 | 52 | 483.77 | -9.6% | 100 | 0.94 |
|
BEN
|
33.28 | 16.9B | 20.80 | 1.44 | 15.24 | — | — | 67 | 30 | 50.32 | +36.9% | 62 | 1.42 |
|
MKTX
|
163.24 | 5.7B | 18.75 | 4.64 | 12.38 | — | — | 67 | 57 | 161.94 | -0.6% | 97 | 0.14 |
|
IVZ
|
32.44 | 14.3B | — | 1.17 | 13.92 | — | — | 66 | 56 | 83.56 | +88.3% | 58 | 0.77 |
|
ICE
|
161.90 | 90.9B | 22.51 | 3.08 | 14.36 | — | — | 62 | 48 | 176.04 | +6.3% | 65 | 0.69 |
|
WTW
|
341.83 | 31.7B | 20.29 | 4.13 | 13.71 | — | — | 62 | 57 | 344.71 | +0.6% | 70 | 0.92 |
|
CBOE
|
294.98 | 30.8B | 24.94 | 5.73 | 15.87 | — | — | 61 | 53 | 245.87 | -12.5% | 93 | 0.29 |
|
FDS
|
309.52 | 11.0B | 21.19 | 5.42 | 12.86 | — | — | 60 | 57 | 282.56 | -6.5% | 86 | 0.77 |
|
SPGI
|
444.70 | 131.1B | 26.64 | 4.16 | 17.00 | — | — | 59 | 46 | 390.81 | -8.7% | 82 | 0.50 |
|
AON
|
327.43 | 69.5B | 17.75 | 7.24 | 12.52 | — | — | 58 | 53 | 270.77 | -13.0% | 70 | 1.65 |
|
CME
|
281.95 | 101.4B | 23.65 | 3.82 | 16.83 | — | — | 58 | 48 | 272.32 | -2.5% | 64 | 0.13 |
|
GPN
|
92.24 | 24.4B | — | 1.03 | 12.62 | — | — | 58 | 56 | 239.90 | +89.7% | 44 | 0.99 |
|
LPLA
|
361.89 | 28.5B | 28.30 | 4.95 | 14.06 | — | — | 58 | 46 | 305.95 | -11.1% | 83 | 1.33 |
|
NDAQ
|
97.66 | 54.6B | 28.55 | 4.54 | 19.13 | — | — | 57 | 45 | 80.60 | -12.6% | 78 | 0.78 |
|
V
|
378.26 | 644.6B | 28.99 | 18.08 | 23.13 | — | — | 52 | 38 | 159.92 | -43.3% | 90 | 0.67 |
|
MA
|
585.57 | 509.1B | 31.32 | 90.74 | 23.62 | — | — | 51 | 35 | 232.78 | -45.2% | 90 | 4.39 |
|
MCO
|
499.78 | 86.6B | 34.69 | 28.91 | 23.34 | — | — | 48 | 35 | 193.82 | -45.9% | 91 | 2.44 |
|
MSCI
|
572.76 | 41.6B | 31.55 | — | 23.86 | — | — | 48 | 22 | 431.72 | -13.8% | 88 | -2.36 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.